News Coverage for
Bio-Solutions Corp. (OTCQB: BISU) - August
27, 2013 |
- Last Trade: $
- Change:
- Open: $
- High: $
- Low: $
- Volume:
| Company Snapshot |
Bio-Solutions Corp.
1250 NE Loop 410
Suite:200
San Antonio, TX 78209
www.biosolutionscorp.com
Directors:
William Gallagher CEO, CFO
Tel: 210-378-8104
Email: info@biosolutionscorp.com
Ticker Symbol: BISU
Exchange: OTCQB
Shares Outstanding: 156,943,593
Float: APX 15,000,000 +/-
52 Week Low: $0.0065
52 Week High: $0.032
|
| BISU Mobi Site |
Never miss news alerts from
BISU -
Text PRESS to 545454 for
Free News Alerts
|
Bio-Solutions Corp. Announces National Direct
Response Marketing Campaign for Type2Defense™
GVP Digital
Media, a top direct response marketing company
to employ unique strategy to launch innovative
consumer product
SAN ANTONIO,
August 28, 2013 /PRNewswire via COMTEX/
Bio-Solutions Corp. (OTCQB: BISU) today
announces a major step in their company’s
expansion process across the USA and commitment
to growth across America; as management
celebrates the national roll-out of a Direct
Response Infomercial and Marketing Campaign for
it’s flagship product Type2Defense™.
Get
News
Alerts &
Stock Updates for
Bio-Solutions
delivered
directly to your Mobile Phone. Text
PRESS
to 545454
(News alerts are free; however standard
message & data rates may apply. Check with your
carrier for more details.)
 Type2Defense™
is a new dietary supplement that has been
developed to help support healthy blood glucose
levels in health-conscious individuals and those
diagnosed with Type 2 Diabetes. The Product’s
goal is to provide a safe and natural supplement
that will assist in the stabilization of healthy
glucose levels along with providing strong
antioxidants.
Bill Gallagher, CEO of Bio-Solutions Corp said,
“We are very excited to be launching our unique
product via direct response television in the
USA, and especially feeling confident that
partnering with GVP Digital Media will give us
the edge for a successful campaign."
Compared to other consumer groups, diabetics are
1.6 times more likely to use alternative
medicine either exclusively or as a complement
to traditional treatment. GVP Digital Media, a
leader in Direct Response, will begin to
actively market Type2Defense through their media
contacts and network of brokers, sales
consultants and agents. GVP has already started
test marketing Type2Defense in a National radio
campaign.
“We are extremely excited to be partnering with
Type2Defense™,” said Harry Oates, President of
Direct Response Marketing for GVP Digital Media.
“We believe that they offer a truly innovative
and incredible product that today’s consumers
will soon be discovering through the direct
response marketing endeavour we’re engaging in.”
Bio-Solutions has already opened the retail
marketplace on Amazon, and now television, radio
and magazine advertising will support product
sales and drive consumers to purchase the
products, also through social media and their
website.
Gallagher added “We will also be offering
additional products as line extensions after the
initial product launch. These may be at various
flavors that will widen existing sales. “ The
demand for natural products that effectively
control glucose continues to rise. Even in times
of general economic distress, consumers increase
their consumption of natural health products.
Effective organic products likeType2 Defense can
improve everyday wellbeing and save money on
future medical costs by maintaining health.
About Bio-Solutions Corp.
Bio-Solutions Corp. markets new and very
effective organic products; our lead product is
Type2 Defense™. Type2Defense™ a Diabetic
Supplement Drink. Type2Defense™ is a new dietary
supplement that has been developed to help
support healthy blood glucose levels in
health-conscious individuals and those diagnosed
with Type 2 Diabetes. The Product’s goal is to
provide a safe and natural supplement that will
assist in the stabilization of healthy glucose
levels along with providing strong antioxidants.
Consumers can find more information about the
company and its products by going to http://www.BioSolutionsCorp.com.
"Safe Harbor" Statement under the Private
Securities Litigation Reform Act of 1995: This
release includes forward-looking statements
intended to qualify for the safe harbor from
liability established by the Private Securities
Litigation Reform Act of 1995. All statements
which address actual results could differ
materially from those expressed or implied in
forward-looking statements. These statements are
made on the basis of management's views and
assumptions. As a result, there can be no
assurance that management's expectations will
necessarily come to pass. These forward-looking
statements generally can be identified by
phrases such as management "believes",
"expects", "anticipates", "foresees",
"forecasts", "estimates" or other words or
phrases of similar import. Similarly, statements
in this release that describe the Company's
business
strategy, outlook, objectives, plans, intentions
or goals also are forward-looking statements.
All such forward-looking statements are subject
to certain risks and uncertainties that could
cause actual results to differ materially from
those in forward looking statements. Management
cautions that the ability to attract clients and
generate business may be affected by a decline
in the Company's financial ratings, the
competitive environment, the Company's ability
to raise sufficient capital to meet the
collateral requirements associated with its
current business and to fund the Company's
continuing operations and changes in market
conditions.
SOURCE Bio-Solutions Corp
About Bio-Solutions Corp. (OTCQB: BISU) |
Bio-Solutions Corp, Owns and Markets Type2
Defense(TM) (the “Product” or the “Supplement”)
is a glucose control dietary supplement powder
formulated to support healthy glucose levels in
addition to maintaining healthy blood pressure.
Packaged with 30 packets to a box, the product
powder drink mix delivery system has been
developed to support healthy glucose levels for
type 2 diabetics and pre-diabetics. The product
is also effective in controlling hypertension
and has strong antioxidant powers.
 Bio-Solutions
Corp intends to sell and market the Product on
the Internet. The target market is type 2 and
pre-diabetics. The Product is delivered in 10
gram plastic packets (i.e. Emergent- C)
conveniently packaged in a box of 30 servings.
The targeted market is health conscious
individuals that have been diagnosed as Type II
diabetics or individuals who are concerned with
pre-diabetic symptoms.
The company and Management believe that there is
a growing Diabetic TARGET market place that
lacks adequate healthy tools to maintain healthy
blood glucose levels. Type2 Defense is a powder
blend of natural ingredients that has been
developed to maintain healthy blood glucose
levels. The
Type2 Defense powder blend is a flavorful
supplement when mixed with water becomes an
effective vehicle that encourages its target
market with a convenient and all natural pure
health beverage containing green tea blended
with cinnamon and blueberry flavoring along with
Type2 Defense proprietary blend. The Product’s
goal is to provide a safe and natural supplement
that will assist in the stabilization of healthy
glucose levels along with providing strong
antioxidants.
Protect your body naturally.
The Company is pleased to announce a new era for
Bio-Solutions Corp. (OTCBB:BISU). The company
markets new and very effective
organic products; our lead product is Type2
Defense™. Type2Defense™ a Diabetic Supplement
Drink.
“This company recognizes the diabetic epidemic
that is happening in this country and throughout
the world. We are excited to offer such a
dynamic nutritional supplement that supports
healthy living in the diabetic community”, says
EVP Bill Gallagher. The company’s focus is now
on type 2 and pre-diabetic products. The
targeted market for Type2 Defense™ is heath
conscious individuals that have been diagnosed
as Type II diabetics or individuals who are
concerned with pre-diabetic symptoms.
Bio-Solutions Corp. acquired Type2 Defense™
brand in September of 2012, including all
formulas, copyrights, trademarks, records and
research. The Company has launched the new
product to tap into the rapidly growing demand
for diabetic and functional
supplementation.Type2 Defense™ will soon be sold
on the company’s website www.type2defense.com
(currently under development).
Recent Bio-Solutions Corp. (OTCQB: BISU) |
Bio-Solutions Corporation Announces Campaign on
Lockerdome.com to Help Raise Money for the
Benefit of Juvenile Diabetes
SAN ANTONIO,
August 27, 2013 /PRNewswire via COMTEX/ --
Bio-Solutions Corporation (OTCQB: BISU) is
pleased to announce that we have initiated a
campaign on Lockerdome.com to help raise money
for the benefit of Juvenile Diabetes.
Lockerdome.com is the premier destination on the
internet for both professional and amateur
athletes. Monthly traffic to Lockerdome.com is
in excess of 14 million visitors per month and
Bio-Solutions is confident that it can reach
athletes who have diabetes through
Lockerdome.com and help them reach their
training potential by using the company's
product, Type 2 Defense.
The Bio-Solutions Corp. page on Lockerdome.com
will allow young athletes with diabetes to
interact with pro athletes with diabetes. This
one on one interaction with the pros will show
young diabetics that diabetes is not an obstacle
to achieving greatness. The pro ranks are full
of star athletes who have made it to the top
without letting diabetes get in their way. We
invite everyone who is interested to check out
the page for news on product endorsers and
product giveaways.
Every order that originates from the
Lockerdome.com campaign, will result in a
portion of net proceeds being donated to
Juvenile Diabetes. Both Bio-Solutions Corp and
Lockerdome.com support the activities of
Juvenile Diabetes on a regional and national
basis. We encourage everyone to visit the new
Bio-Solutions Corp page on Lockerdome.com by
clicking biosolutionscorp.lockerdome.com.
Bio-Solutions Corporation Launches
www.Type2Defense.com to Take Online Orders
SAN
ANTONIO, TEXAS, Jul 09, 2013 (Marketwired via
COMTEX) -- Bio-Solutions Corp. (OTCQB:
BISU)(PINKSHEETS: BISU) www.BioSolutionsCorp.com
- In a joint effort to accommodate the growing
demand for the company's product, Bio-Solutions
Corp. has launched its official online retail
store at www.Type2Defense.com while maintaining
its distribution agreement with the Amazon store
Healthy Provisions. Consumers will now
have two options when ordering the product;
through www.Type2Defense.com or Healthy
Provisions on Amazon. This will enable
Bio-Solutions Corp. to broaden its consumer base
and reach out to clients on a global scale where
changing lifestyles and health awareness among
consumers is expected to drive the health
supplements market in the years to come. Type2
Defense(TM) will cater to type2 diabetes
patients, which are 90-95% of all diabetics.
"The market of diabetes supplements is
witnessing a steady growth in the last decade
mainly due to the growing awareness among
consumers of the effect of consuming health
supplements. Some of the major factors driving
the global supplements market include the
growing global ageing population and the growing
concern among consumer to stay healthy and fit.
Huge opportunities lie in the diabetes
supplement industry, where growth is driven
mainly due to the demand from knowledgeable
consumers looking for a healthy alternative. Our
company is strategically positioned to benefit
from this," said Bill Gallagher, president and
CEO at Bio-Solutions Corp.
Bio-Solutions Corp. has hired Josh Williams, an
independent consultant to brand Type2Defense(TM)
thru mainstream media via multiple channels -
including high-profile, profession athlete
endorsements.
Type2Defense(TM) Available on
the Amazon Healthy Provisions Online Store
SAN ANTONIO,
TEXAS, Jul 08, 2013 (Marketwired via COMTEX) --
Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS:
BISU)
(www.BioSolutionsCorp.com)
has done it! In this first step to the company's
expansion process across the USA and commitment
to growth across America, management celebrates
the national roll-out of its flagship product
Type2Defense(TM) on the Healthy Provisions
Amazon store via its partnership agreement with
Kee Holdings Inc. The product can be purchased
by following the online ordering link on the
company website at:
www.biosolutionscorp.com.
Kee Holdings Inc. is a leading procurer of
health, nutrition and wellness products leading
the way to many of the internet giants online
today. Since 2006, Kee Holdings has grown to
represent over 7,500 well-known consumer
products and offers both wholesale and drop ship
fulfillment strategies to clients such as
Amazon.com and Overstock.com. Kee Holdings will
be managing all product orders and shipping for
Bio-Solution Corp's on-line sales.
Type2Defense(TM) is a new dietary supplement
that has been developed to help support healthy
blood glucose levels in health-conscious
individuals and those diagnosed with Type 2
Diabetes. The Product's goal is to provide a
safe and natural supplement that will assist in
the stabilization of healthy glucose levels
along with providing strong antioxidants.
"We are very excited to be bringing
Type2Defense(TM) to the consumer on the Healthy
Provisions Amazon store and we highly appreciate
the support that Amazon and its partners offer
to manufacturers and suppliers. We believe that
there is a growing market place that lacks
adequate healthy tools to maintain healthy blood
glucose levels. Type2Defense(TM) is aimed at
filling in that gap and our company is confident
that it will benefit from the $15 billion dollar
U.S diabetes market," said Bill Gallagher,
president and CEO at Bio-Solutions Corporation.
Consumers can find more information about the
product by going to http://www.biosolutionscorp.com/products/..
Bio-Solutions Corporation Completes Initial
Production of Diabetic Product, Type2 Defense
SAN ANTONIO, TEXAS, Jun 27, 2013
(Marketwired via COMTEX) -- Bio-Solutions
Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is
pleased to announce that the company has
completed its initial order of the diabetic
product Type2 Defense with Nutricap Labs located
in Farmingdale, New York. The successful
completion of the initial production order is an
important milestone for Bio-Solutions
Corporation. The company is now positioned to
distribute final product samples to the
different groups that are presently considering
endorsing the Type2 Defense product and begin
set-up of proper distribution channels for the
product.
Type2 Defense
is a preventative supplement for people who are
diabetic or who are pre-diabetic. The product
helps regulate blood sugar and blood pressure
levels in diabetic and pre-diabetic subjects,
especially for those who are insulin-resistant.
"The company recognizes the diabetic epidemic
that is happening in this country and throughout
the world. We are excited to now be able to
offer such a dynamic nutritional supplement that
supports healthy living in the diabetic
community" says CEO Bill Gallagherr.
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM) is a third party
publishing provider which disseminates
electronic information through multiple online
media channels. FNMG's intended purposes are to
deliver market updates and news alerts issued
from private and publicly trading companies as
well as providing coverage and increased
awareness for companies that issue press to the
public via online newswires. FNMG and its
affiliated companies are a news dissemination
and financial marketing solutions provider and
are NOT a registered
broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to
sell or offer to buy any security. FNMG's market
updates, news alerts and corporate profiles are
NOT a solicitation or recommendation to buy,
sell or hold securities. An offer to buy or sell
can be made only with accompanying disclosure
documents from the company offering or selling
securities and only in the states and provinces
for which they are approved. The material in
this release is intended to be strictly
informational and is NEVER to be construed or
interpreted as research material. All readers
are strongly urged to perform research and due
diligence on their own and consult a licensed
financial professional before considering any
level of investing in stocks. The companies that
are discussed in this release may or may not
have approved the statements made in this
release. Information in this release is derived
from a variety of sources that may or may not
include the referenced company's publicly
disseminated information. The accuracy or
completeness of the information is not warranted
and is only as reliable as the sources from
which it was obtained. While this information is
believed to be reliable, such reliability cannot
be guaranteed. FNMG disclaims any and all
liability as to the completeness or accuracy of
the information contained and any omissions of
material fact in this release. This release may
contain technical inaccuracies or typographical
errors. It is strongly recommended that any
purchase or sale decision be discussed with a
financial adviser, or a broker-dealer, or a
member of any financial regulatory bodies.
Investment in the securities of the companies
discussed in this release is highly speculative
and carries a high degree of risk. FNMG is not
liable for any investment decisions by its
readers or subscribers. Investors are cautioned
that they may lose all or a portion of their
investment when investing in stocks.
This release is not without bias, and is
considered a conflict of interest if
compensation has been received by FNMG for its
dissemination. To comply with Section 17(b) of
the Securities Act of 1933, FNMG shall always
disclose any compensation it has received, or
expects to receive in the future, for the
dissemination of the information found herein on
behalf of one or more of the companies mentioned
in this release. For services performed FNMG has
been compensated three thousand nine fifty
hundred dollars for coverage on this BISU news
release by a non-affiliated third party. FNMG
HOLDS NO SHARES OF Bio-Solutions (OTCQB: BISU)
This release contains "forward-looking
statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and
Section 21E the Securities Exchange Act of 1934,
as amended and such forward-looking statements
are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe
future expectations, plans, results, or
strategies and are generally preceded by words
such as "may", "future", "plan" or "planned",
"will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are
cautioned that such statements are subject to a
multitude of risks and uncertainties that could
cause future circumstances, events, or results
to differ materially from those projected in the
forward-looking statements, including the risks
that actual results may differ materially from
those projected in the forward-looking
statements as a result of various factors, and
other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings
made by such company with the Securities and
Exchange Commission. You should consider these
factors in evaluating the forward-looking
statements included herein, and not place undue
reliance on such statements. The forward-looking
statements in this release are made as of the
date hereof and FNMG undertakes no obligation to
update such statements.
|
